Drawing for LUMEN BIOSCIENCE

USPTO serial 90767302

LUMEN BIOSCIENCE

Reviewed by CopyMark Law Group

Reg. 7778829Status 700Registered
Filing date
Status date
Registration date
Apr 29, 2025
Examiner
BONEN-CLARK, HOPE MICHELLE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LUMEN BIOSCIENCE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Emily M. Haas

Emily M. Haas MICHAEL BEST & FRIEDRICH LLP4509 Creedmoor Road, Suite 501Raleigh, NC 27512United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical additives derived from microalgae, namely, cyanobacteria, for use in the manufacture of pharmaceuticals, cosmetics, veterinary preparations, and foodstuffsACTIVEAug 29, 2023
005Vaccine preparations; adjuvants for use with vaccines; therapeutic antibodies for use as immunotherapeutic agents for targeting toxins, viruses and enterotoxic bacteria; biologic preparations for medical and therapeutic purposes, namely, the treatment and prevention of infectious diseases, deficiency diseases, hereditary diseases, physiological diseases, metabolic diseases, autoimmune diseases and gastrointestinal diseases; therapeutic agents for medical purposes, namely, biologic drugs targeted to treat specific diseases, namely, infectious diseases, deficiency diseases, hereditary diseases, physiological diseases, metabolic diseases, autoimmune diseases and gastrointestinal diseasesACTIVEAug 29, 2023

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 29, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Apr 29, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 4, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 4, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 7, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 7, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 7, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 4, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 4, 2025CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 19, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 18, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 4, 2024IUAFUSE AMENDMENT FILED—
Nov 4, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 13, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 4, 2024EX3GSOU EXTENSION 3 GRANTED—
Jun 4, 2024EXT3SOU EXTENSION 3 FILED—
Jun 4, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 1, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 1, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 1, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 1, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 1, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 23, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 21, 2023EX2GSOU EXTENSION 2 GRANTED—
Dec 21, 2023EXT2SOU EXTENSION 2 FILED—
Dec 21, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 11, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 7, 2023EX1GSOU EXTENSION 1 GRANTED—
Apr 7, 2023EXT1SOU EXTENSION 1 FILED—
Apr 7, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 27, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 12, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 26, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 26, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Sep 26, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 26, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 26, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 14, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 14, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 14, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 16, 2022CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Mar 16, 2022ALIEASSIGNED TO LIE—
Mar 16, 2022GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Mar 16, 2022GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Mar 16, 2022CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Mar 1, 2022DOCKASSIGNED TO EXAMINER—
Sep 1, 2021MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 31, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 14, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance